Rula Geha, MD

Clinician, Aluna Science

Dr. Rula C. Geha, MD, is a physician and life sciences executive with nearly two decades of clinical experience, specializing in oncology across inpatient and outpatient settings. She serves as Vice President of Life Sciences and Senior Medical Director of Corporate Health at MacAndrews and Forbes, where she leads corporate health strategy, conducts due diligence on emerging therapeutics and biotechnologies, and oversees philanthropic medical initiatives for the company's 100 million dollar foundation. She has built high-impact clinical programs, including launching an in-house medical clinic and developing custom medical record and inventory systems.

Dr. Geha completed fellowships in surgical oncology and endocrine surgery at the Hospital of the University of Pennsylvania and Montefiore Medical Center. She previously practiced as an attending surgeon at Montefiore and Crystal Run Healthcare, performing complex procedures and conducting research in neuroendocrine, endocrine, and ovarian cancers. She earned her MD from Case Western Reserve University, completed residency at Columbia Presbyterian, and holds degrees in molecular biology and biochemistry from Wesleyan University.

View LinkedIn

Credentials & certifications

Undergraduate:
BA/BS in Molecular Biology and Biochemistry from Wesleyan University
Medical school:
MD from Case Western Reserve University School of Medicine
Residency:
General Surgery at Columbia Presbyterian (Columbia University Medical Center)
Fellowships:
Surgical Oncology at the Hospital of the University of Pennsylvania; Endocrine Surgery at Montefiore Medical Center

Specialist areas

Surgical Oncology
Breast Oncology
Corporate Health Strategy
Health Economics & Outcomes Research

Experience

Education & training

Featured publications

All publications

Cushings Syndrome Book Chapter 2018
Geha RC, Libutti SK | 2018, Textbook of Complex General Surgical Oncology (eds. Balch and Morita), Book Chapter
End-Tidal CO2 Pulmonary Embolism Poster 2003
Geha RC, Fleischer B, Chenitz K, Aranoff S, Widmann W | Jan 2003, Poster — 32nd Society of Critical Care Medicine, San Antonio, TX
Water Suppression without Signal Loss HR-MAS NMR Cells Tissues
Singer S, DeCarolis P, O'Connor R, Sambol EB, Geha RC, Chen JH | Feb 2005, Poster — Keystone Symposia: Frontiers of NMR in Molecular Biology IX, Banff, Alberta, Canada
Flavopiridol Superior Imatinib Mesylate Gleevac GIST
Sambol EB, Kennealey PT, Motwani M, Geha RC, DeCarolis P, O'Connor R, Chen JH, Schwartz GK, Singer S | Feb 2005, Oral Presentation — Society of University Surgeons 66th Annual Meeting, Nashville, TN
Support Vector Machine SVM NMR Liposarcoma Subtypes
Geha RC, Eisenbud D, Sambol EB, Kennealey PT, DeCarolis P, Sander C, Chen JH, Singer S | Mar 2005, Oral Presentation — Society of Surgical Oncology 58th Annual Cancer Symposium, Atlanta, GA
Water Interaction Membrane Phospholipid Protein Proton HR-MAS NMR
Chen JH, DeCarolis P, O'Connor R, Sambol EB, Geha RC, Singer S | May 2005, Poster — 13th ISMRM, Miami, FL
NMR Detectable Cholesterol Early Marker Tumor Response Cytotoxic Chemotherapy
Kennealey PT, Sambol EB, DeCarolis P, Geha RC, She Y, Schwartz GK, Chen JH, Singer S | Oct 2005, Oral Presentation — 91st Clinical Congress American College of Surgeons, San Francisco, CA
Flavopiridol Targets KIT Transcription and Induces Apoptosis in Gastrointestinal Stromal Tumor Cells
Sambol EB, Ambrosini G, Geha RC, Kennealey PT, DeCarolis P, O'Connor R, Motwani M, Chen JH, Schwartz GK, Singer S | Jun 1, 2006, Cancer Res. 66(11):5858-66
Aprotinin Safety and Patient Selection Cardiovascular Surgical Procedures
Geha RC, Sternberg R | Apr 2007, Prepared for Cedars-Sinai Health System, Zynx Health, Los Angeles, CA
Restoration of C/EBPa in dedifferentiated liposarcoma induces G2/M cell cycle arrest and apoptosis
Wu YV, Okada T, DeCarolis P, Socci N, O'Connor R, Geha RC, Joy Somberg C, Antonescu C, Singer S | Apr 2012, Genes Chromosomes Cancer. 51(4):313-27
Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-alpha leads to synergistic antitumor activity
Yuan Z, Syrkin G, Adem A, Geha RC, Pastoriza J, Vrikshajanani C, Smith T, Quinn TJ, Alemu G, Cho H, Barrett CJ, Arap W, Pasqualini R, Libutti SK | Nov 16, 2012, Cancer Gene Ther.
Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis
Yuan Z, Syrkin G, Adem A, Geha RC, Pastoriza J, Vrikshajanani C, Smith T, Quinn TJ, Alemu G, Cho H, Barrett CJ, Arap W, Pasqualini R, Libutti SK | Mar 15, 2016, Oncotarget. 7(11):12633-50
End-Tidal CO2 Pulmonary Embolism Oral 2002
Geha RC, Fleischer B, Chenitz K, Aranoff S, Widmann W | Sep 2002, Oral Presentation — NJ Chapter of Critical Care Medicine Conference, New Brunswick, NJ
Role of fecal incontinence in contamination of the environment with vancomycin-resistant enterococcus
Mayer R, Geha RC, Helfand MS, Hoyan CK, Salata RA, Donskey CD | Jun 2003, American Journal of Infection Control. 31(4):221-5
Direct Observation of Membrane Lipid Hydration
Chen JH, DeCarolis P, O'Connor R, Sambol EB, Geha RC, Singer S | Feb 2005, Oral Presentation — Keystone Symposia: Frontiers of NMR in Molecular Biology IX, Banff, Alberta, Canada
Flavopiridol Monotherapy Antiproliferative Soft Tissue Sarcoma
Sambol EB, Kennealey PT, Motwani M, She Y, Geha RC, O'Connor R, Schwartz G, Singer S | Mar 2005, Oral Presentation — Society of Surgical Oncology 58th Annual Cancer Symposium, Atlanta, GA
Flavopiridol active agent GIST imatinib mesylate resistance
Sambol EB, Motwani M, Ambrosini G, Geha RC, DeCarolis P, O'Connor R, Chen JH, Schwartz GK, Singer S | Apr 2005, Poster — American Association of Cancer Research 96th Annual Meeting, Anaheim, CA
Liposarcoma Subtyping Support Vector Machine HR-MAS NMR
Singer S, Eisenbud D, O'Connor R, DeCarolis P, Geha RC, Sambol EB, Sander C, Chen JH | May 2005, Poster — 13th ISMRM, Miami, FL
High-Resolution MAS NMR Spectroscopy Detection of the Spin Magnetization Exchange by Cross-Relaxation and Chemical Exchange in Intact Cell lines and Human Tissue Specimens
Chen JH, Sambol EB, DeCarolis P, O'Connor R, Geha RC, Singer S | Jun 2006, Magn Reson Med. 55(6):1246-56
Ribonucleotide Reductase M2 Subunit Novel Therapeutic Target Liposarcoma
Geha RC, Wu W, Sambol EB, DeCarolis P, O'Connor R, Schwartz GK, Singer S | 2006, Oral Presentation — 92nd Clinical Congress of the American College of Surgeons, Chicago, IL
Laparoscopic radical cholecystectomy
Gumbs AA, Milone L, Geha RC, Delacroix J, Chabot JA | 2009, J Laparoendosc Adv Surg Tech A
Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model
Quinn TJ, Yuan Z, Adem A, Geha RC, Vrikshajanani C, Koba W, Fine E, Hughes DT, Schmid HA, Libutti SK | Dec 2012, Surgery. 152(6):1068-77
MarginProbe Poster 2015
Geha RC, Taback BT, Feldman S | Apr 2015, Poster — American Society of Breast Surgeons 16th Annual Meeting, Orlando, FL
A Cost-Effective Handheld Breast Scanner Poster 2016
Geha RC, Broach R, De La Cruz L, Thrash H, Campisi M, Englander B, Shah M, Brooks AD | Apr 2016, Poster — American Society of Breast Surgeons 17th Annual Meeting, Dallas, TX